Expression of MECP2 to cause pathogenic symptoms of MDS in mouse models of RTT is between 1.6 and 2.4 times the normal level [25,120,121] and about a 3.8-fold overexpression is lethal [120]. This evidence concerns the gene MECP2 and myelodysplastic syndrome.